We are live on ! Find out more
ORIA

Orion Biotech Opportunities Corp. Class A Ordinary Share
ORIA

Delisted

ORIA was delisted on the 28th of April, 2023.

Back to rankings

35 hedge funds and large institutions have $112M invested in Orion Biotech Opportunities Corp. Class A Ordinary Share in 2021 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 2

30% more capital invested

Capital invested by funds: $86.2M → $112M (+$26.1M)

30% more funds holding

Funds holding: 27 → 35 (+8)

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

Holders
35
Holders Change
+8
Holders Change %
+29.63%
% of All Funds
0.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
2
Reduced
3
Closed
2
Calls
$48K
Puts
–
Net Calls
+$48K
Net Calls Change
+$48K

Top Buyers

Rank Fund Capital Flow
1
CSS
Cubist Systematic Strategies
Connecticut
+$6.23M
2
PC
Periscope Capital
Ontario, Canada
+$5.88M
3
SCM
Shaolin Capital Management
Florida
+$5.13M
4
KC
Kepos Capital
New York
+$4.91M
5
Millennium Management
Millennium Management
New York
+$2.45M

Top Sellers

Rank Fund Capital Flow
1
PAM
Panagora Asset Management
Massachusetts
-$130K
2
HighTower Advisors
HighTower Advisors
Illinois
-$109K
3
EAM
Exos Asset Management
New York
-$38.9K
4
RCM
Radcliffe Capital Management
Pennsylvania
-$6.17K
5
WAM
Wolverine Asset Management
Illinois
-$6K
Name Holding Trade Value Shares
Change 		Change in
Stake
6CM
1
683 Capital Management
New York
$11.6M – – –
FTCM
2
Fir Tree Capital Management
New York
$9.83M – – –
SCC
3
Spring Creek Capital
Kansas
$7.8M – – –
MI
4
MMCAP International
Cayman Islands
$7.74M – – –
CSS
5
Cubist Systematic Strategies
Connecticut
$6.14M +$6.23M +635,053 New
ACA
6
Arena Capital Advisors
California
$5.85M – – –
PC
7
Periscope Capital
Ontario, Canada
$5.85M +$5.88M +599,500 New
HighTower Advisors
8
HighTower Advisors
Illinois
$5.61M -$109K -11,150 -2%
SCM
9
Shaolin Capital Management
Florida
$5.05M +$5.13M +522,452 New
FIG
10
Fortress Investment Group
New York
$5.03M – – –
ACM
11
Atalaya Capital Management
New York
$4.92M – – –
KC
12
Kepos Capital
New York
$4.88M +$4.91M +500,000 New
RCM
13
Radcliffe Capital Management
Pennsylvania
$3.9M -$6.17K -628 -0.2%
AGC
14
Angelo Gordon & Co
New York
$2.9M – – –
Marshall Wace
15
Marshall Wace
United Kingdom
$2.66M – – –
UOC
16
UBS O'Connor
Illinois
$2.51M +$67.5K +6,880 +3%
SC
17
Sculptor Capital
New York
$2.42M +$1.23M +125,000 +100%
Millennium Management
18
Millennium Management
New York
$2.42M +$2.45M +250,000 New
AA
19
AQR Arbitrage
Connecticut
$1.93M – – –
DCM
20
DG Capital Management
New York
$1.72M – – –
RCM
21
Rivernorth Capital Management
Florida
$1.71M – – –
WRBC
22
W.R. Berkley Corp
Connecticut
$1.67M – – –
PMAM
23
Picton Mahoney Asset Management
Ontario, Canada
$1.46M – – –
SCM
24
Segantii Capital Management
Hong Kong
$1.45M – – –
DCM
25
Dupont Capital Management
Delaware
$976K – – –
1
2

ORIA Hedge Fund Activity: Q4 2021 in Review

35 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) for Q4 2021, worth a combined $112M — up 30% from $86.2M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new ORIA positions and 2 closed out — a net gain of 8 holders — while 2 added to existing stakes and 3 trimmed.

The largest buyer was Cubist Systematic Strategies, opening a new position worth an estimated $6.23M. The largest seller was Panagora Asset Management, exiting entirely with an estimated $130K sold.

  • 35 institutional investors held Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) as of Q4 2021, up from 27 in Q3 2021.
  • Funds reported $112M of Orion Biotech Opportunities Corp. Class A Ordinary Share stock for Q4 2021, up 30% quarter-over-quarter.
  • 10 funds opened new Orion Biotech Opportunities Corp. Class A Ordinary Share positions in Q4 2021 and 2 closed out, a net change of +8 holders.
  • The largest Orion Biotech Opportunities Corp. Class A Ordinary Share buyer in Q4 2021 was Cubist Systematic Strategies, an estimated $6.23M added.
  • The largest Orion Biotech Opportunities Corp. Class A Ordinary Share seller in Q4 2021 was Panagora Asset Management, an estimated $130K sold.

Based on aggregated 13F filings for Q4 2021.